TERN's three largest insider shareholders as of March 23, 2026 are Biosciences Fund V, L.P. Lav (TenPercentOwner, 529.76K shares), Hongbo Lu (Director, 476.19K shares), Amy L. Burroughs (Chief Executive Officer, 288.98K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Biosciences Fund V, L.P. Lav | 0 | 529,762 | 28 Nov, 2022 | |
| Hongbo Lu | 0 | 476,190 | 17 Sep, 2024 | |
| Amy L. Burroughs | Chief Executive Officer | 288,976 | 0 | 18 Feb, 2026 |
| Amy L. Burroughs | Chief Executive Officer | 288,976 | 0 | 17 Mar, 2026 |
| Opportunity, Llc Vivo | 0 | 268,573 | 03 Apr, 2024 | |
| Emil Kuriakose | Chief Medical Officer | 106,615 | 0 | 16 Jan, 2026 |
| Andrew Gengos | Chief Financial Officer | 101,788 | 0 | 16 Jan, 2026 |
| Seokho Bryan Yoon | Coo And General Counsel | 91,940 | 0 | 04 Jun, 2024 |
| Erin Quirk | President, Head Of Rd | 75,000 | 0 | 25 Jan, 2024 |
| Mark J. Vignola | Chief Financial Officer | 74,752 | 0 | 06 Jan, 2025 |
| Senthil Vel Sundaram | Chief Executive Officer | 9,770 | 0 | 02 Jun, 2023 |
| Melita Sun Jung | Chief Business Officer | 2,250 | 0 | 03 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Amy L. Burroughs | Common Stock | A | 14,583 | $4.64 | 303,559 | D | M |
| 16 Mar, 2026 | Amy L. Burroughs | Common Stock | D | 11,813 | $46.57 | 291,746 | D | S |
| 16 Mar, 2026 | Amy L. Burroughs | Common Stock | D | 2,770 | $47.30 | 288,976 | D | S |
| 16 Mar, 2026 | Amy L. Burroughs | Stock Option (Right to Buy) | D | 14,583 | $0.00 | 955,534 | D | M |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | A | 14,583 | $4.64 | 303,559 | D | M |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | A | 14,583 | $4.64 | 303,559 | D | M |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 2,341 | $38.07 | 301,218 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 2,341 | $38.07 | 301,218 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 8,159 | $39.22 | 293,059 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 8,159 | $39.22 | 293,059 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 4,083 | $39.80 | 288,976 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Common Stock | D | 4,083 | $39.80 | 288,976 | D | S |
| 17 Feb, 2026 | Amy L. Burroughs | Stock Option (Right to Buy) | D | 14,583 | $0.00 | 970,117 | D | M |
| 17 Feb, 2026 | Amy L. Burroughs | Stock Option (Right to Buy) | D | 14,583 | $0.00 | 970,117 | D | M |
| 01 Feb, 2026 | Jill M. Quigley | Stock Option (Right to Buy) | A | 1,697 | $0.00 | 1,697 | D | A |
| 01 Feb, 2026 | Jeffrey B Kindler | Stock Option (Right to Buy) | A | 1,697 | $0.00 | 1,697 | D | A |
| 01 Feb, 2026 | Robert Azelby | Stock Option (Right to Buy) | A | 1,697 | $0.00 | 1,697 | D | A |
| 01 Feb, 2026 | Radhika Tripuraneni | Stock Option (Right to Buy) | A | 1,697 | $0.00 | 1,697 | D | A |
| 01 Feb, 2026 | Heather D Turner | Stock Option (Right to Buy) | A | 1,697 | $0.00 | 1,697 | D | A |
| 14 Jan, 2026 | Emil Kuriakose | Common Stock | A | 56,250 | $0.00 | 106,615 | D | A |